Bioinformatics Services Market Size, Share, Trends, Industry Analysis Report: By Type, Application (Genomics, Chemo Informatics & Drug Design, Proteomics, Transcriptomic, Metabolomics, and Other Applications), Specialty, End User, and Region (North Americ

The global bioinformatics services market size is expected to reach USD 16,297.10 million by 2034, according to a new study by Polaris Market Research. The report “Bioinformatics Services Market Size, Share, Trends, Industry Analysis Report: By Type, Application (Genomics, Chemo Informatics & Drug Design, Proteomics, Transcriptomic, Metabolomics, and Other Applications), Specialty, End User, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) – Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

Bioinformatics services encompass computational solutions that facilitate the analysis of complex biological data, driving advancements in genomics, proteomics, and drug discovery. A key trend shaping the bioinformatics services market expansion is the increasing integration of artificial intelligence (AI) and machine learning (ML) in bioinformatics, which enhance data processing capabilities and predictive analytics. AI-driven bioinformatics tools improve genomic sequencing accuracy, accelerate biomarker discovery, and optimize drug development workflows. Additionally, advancements in cloud computing have expanded access to bioinformatics services, allowing researchers and organizations to store, share, and analyze large-scale biological datasets efficiently. These developments are expected to drive innovation and efficiency across various bioinformatics applications as AI and cloud-based platforms continue to evolve.

Another trend driving the bioinformatics services market development is the rising adoption of multi-omics approaches, combining genomics, transcriptomics, proteomics, and metabolomics for a comprehensive understanding of biological systems. The integration of multi-omics data improves disease research, facilitating precision medicine and targeted therapies by identifying complex biological interactions. Bioinformatics services play a crucial role in managing and interpreting vast datasets generated from these studies, supported by increasing investments in multi-omics research. Additionally, advancements in high-throughput sequencing and bioinformatics pipelines enable real-time data analysis, improving decision-making in clinical and pharmaceutical applications. As multi-omics research continues to gain traction, the demand for sophisticated bioinformatics services is expected to rise, further driving bioinformatics services market growth.

Bioinformatics Services Market Report Highlights

In terms of specialty, the medical biotechnology segment led the bioinformatics services market in 2024, fueled by its pivotal role in advancing precision medicine, drug discovery, and disease diagnostics.

Based on end user, the academic institutes & research centers segment is anticipated to experience the fastest growth due to the rising focus on genomics, molecular biology, and computational biology research.

North America accounted for the largest share of the global market in 2024, supported by the presence of robust biotechnology and pharmaceutical sectors and significant investments in life sciences research.

The Asia Pacific bioinformatics services market is expected to witness the fastest growth during the forecast period, propelled by increasing biotechnology investments, expanding genomic research, and rising demand for personalized medicine.

A few global key market players include BaseClear BV; BGI Group; CD Genomics; Eurofins Scientific; Fios Genomics; Genewiz (A Brooks Life Sciences Company); Illumina; Medgenome Labs; Microsynth; Neogenomics; Perkinelmer; Psomagen, Inc.; Qiagen N.V.; Source Bioscience; and Thermo Fisher Scientific.

Polaris Market Research has segmented the bioinformatics services market report on the basis of type, application, specialty, end user, and region:

By Type Outlook (Revenue, USD Million, 2020–2034)

Sequencing Services

Data Analysis

Drug Discovery Services

Differential Gene Expression Analysis

Database and Management Services

Other Bioinformatics Services

By Application Outlook (Revenue, USD Million, 2020–2034)

Genomics

Chemo Informatics & Drug Design

Proteomics

Transcriptomic

Metabolomics

Other Applications

By Specialty Outlook (Revenue, USD Million, 2020–2034)

Medical Biotechnology

Animal Biotechnology

Plant Biotechnology

Environmental Biotechnology

Forensic Biotechnology

By End User Outlook (Revenue, USD Million, 2020–2034)

Academic Institutes & Research Centers

Hospitals & Clinics

Pharmaceutical & Biotechnology Companies

CROs

Other End Users

By Regional Outlook (Revenue, USD Million, 2020–2034)

North America

• US
• Canada

Europe

• Germany
• UK
• France
• Italy
• Spain
• Russia
• Netherlands
• Rest of Europe

Asia Pacific

• China
• India
• Japan
• South Korea
• Indonesia
• Malaysia
• Vietnam
• Australia
• Rest of Asia Pacific

Latin America

• Argentina
• Brazil
• Mexico
• Rest of Latin America

Middle East & Africa

• UAE
• Saudi Arabia
• Israel
• South Africa
• Rest of Middle East & Africa

Show more